2018 Help me understand this report
Subcutaneous methotrexate in patients with moderate-to-severe psoriasis: a critical appraisal
Abstract: Warren et al. conclude that the 52-week risk-benefit profile of subcutaneous methotrexate is favourable in patients with psoriasis.
Search citation statements
Paper Sections
Select...
Citation Types
0
0
0
Year Published
2019
2023
Publication Types
Select...
5
Relationship
0
5
Authors
Journals
Cited by 5 publications
References 20 publications
0
0
0
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
